Products and Services
Products and Services
Active pharmaceutical ingredients under development
Product Name
CAS Number
Specification
TP
DMF
Status
Gilteritinib
1254053-43-4
Q4 2025
Q2 2026
Inavolisib
2060571-02-8
Q4 2025
Q2 2026
Ivacaftor
873054-44-5
Q3 2025
Q1 2026
Lactulose
4618-18-2
Q42025
Q1 2026
Lapatinib
231277-92-9
Q4 2025
Q2 2026
Lifitegrast
1025967-78-5
Q4 2025
Q2 2026
Limaprost
74397-12-9
Q4 2025
Q2 2026
Lorlatinib
1454846-35-5
Q3 2025
Q1 2026
Lotilaner
1369852-71-0
Q4 2025
Q2 2026
Luseogliflozin Hydrate
898537-18-3
Q4 2025
Q2 2026
Mirogabalin Besylate
1138245-21-2
Q3 2025
Q1 2026
Nirogacestat hydrobromide
1962925-29-6
Q4 2025
Q2 2026
Pazopanib
444731-52-6
Q1 2026
Q3 2026
Relugolix
737789-87-6
Q4 2025
Q2 2026
Ribociclib
1211441-98-3
Q3 2025
Q1 2026
Rimegepant
1289023-67-1
Q3 2025
Q1 2026
Ritlecitinib
1792180-81-4
Q3 2025
Q1 2026
Rufinamide
106308-44-5
Q4 2025
Q2 2026
SNAC
203787-91-1
Q3 2025
Q4 2025
Scopolamine Hydrobromide
114-49-8
Q3 2025
Q1 2026
Email:
Company Address:
No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China
